missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ DX3-213B

Catalog No. 30040319
Ansicht ändern
Click to view available options
Menge:
10 mg
Packungsgröße:
10 Milligramm
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Menge Packungsgröße
30040319 10 mg 10 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso
Codice prodotto. 30040319 Fornitore R&D Systems™ N. del fornitore 8070/10
 Eingeschränkter Artikel
Estimated Shipment: 27-11-2026
Aggiungi al carrello
Aggiungi al carrello

missing translation for 'validMainframeMsg'

Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso

A Tocris product, part of R&D Systems. Potent NDUFS7 antagonist

DX3-213B is a potent oxidative phosphorylation (OXPHOS) complex I (also known as NDUFS7) antagonist (IC50 = 3.6 nM). DX3-213B impairs ATP generation (IC50 = 11 nM) and inhibits the proliferation of MIA PaCa-2 cells (IC50 = 9 nM) in galactose-containing media. In vivo, DX3-213B significantly delays tumor growth in a syngeneic mouse model of pancreatic cancer. DX3-213B is orally bioavailable.
TRUSTED_SUSTAINABILITY

Specifica

Chemischer Name oder Material (4,4-Difluoro-1-piperidinyl)[(3R)-1-[[4-[(1-methylethyl)sulfonyl]phenyl]sulfonyl]-3-piperidinyl]methanone
CAS 2749555-66-4
Menge 10 mg
Produktlinie Tocris
Ziel Oxidative Phosphorylation Inhibitors
Summenformel C20H28F2N2O5S2
Reinheit 0.97
Titolo del prodotto
Selezionare un problema

Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.